GeoVax Labs, Inc. logo

GeoVax Labs, Inc.

NASDAQ:GOVX

Overview | Financials
Company Name GeoVax Labs, Inc.
Symbol GOVX
Currency USD
Price 2.11
Market Cap 19,910,108
Dividend Yield 0%
52-week-range 1.09 - 11.18
Industry Biotechnology
Sector Healthcare
CEO Mr. David Alan Dodd
Website https://www.geovax.com

An error occurred while fetching data.

About GeoVax Labs, Inc.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and

Related Stocks

Healthcare Triangle, Inc. logo

Healthcare Triangle, Inc.

HCTI

0.938 USD

Predictive Oncology Inc. logo

Predictive Oncology Inc.

POAI

1.2 USD

Precipio, Inc. logo

Precipio, Inc.

PRPO

6.06 USD

Financials

Numbers are in millions USD

Numbers are in millions USD